project id: TCGA-HNSC; case submitter id: TCGA-D6-8569; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 9.1; age at index: 52; days to birth: -19212; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 19212; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 770.0; icd 10 code: C02.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tongue, NOS; synchronous malignancy: No; tissue or organ of origin: Tongue, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: No; cigarettes per day: 2.356164383561644; pack years smoked: 43.0; years smoked: 33.0; is ffpe: false; weight: 41.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.3; longest dimension: 0.5; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-D6-8569-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;